Toll-like receptor/interleukin-1 domain innate immune signalling pathway genetic variants are candidate predictors for severe gastrointestinal toxicity risk following 5-fluorouracil-based chemotherapy Samantha K. KorverRachel J. GibsonJanet K. Coller Review Article 24 November 2018 Pages: 217 - 236
6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability Shengnan DuJeffrey G. SarverWilliam A. Maltese Original Article 13 November 2018 Pages: 237 - 254
Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines Ajimu KeremuAbudusaimi AimaitiXiaoguang Zou Original Article 14 November 2018 Pages: 255 - 264
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals Gordon T. BolgerAlbert LicollariPeter P. Sordillo Original Article 14 November 2018 Pages: 265 - 275
Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B Shuqi ChiYan LiuHongbo Wang Original Article 15 November 2018 Pages: 277 - 287
A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors Masanori ToyodaKoichiro WatanabeHironobu Minami Original Article Open access 16 November 2018 Pages: 289 - 299
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project Marina E. CazzanigaE. Cirueloson behalf of the MACBETH Group Original Article 20 November 2018 Pages: 301 - 318
Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias Renu SinghShailly Mehrotraon behalf of the ETCTN-6745 study team Original Article 20 November 2018 Pages: 319 - 328
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin®), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors Angelica L. QuartinoHanbin LiBert Lum Original Article Open access 22 November 2018 Pages: 329 - 340
Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia Sanjeev KheraAmita TrehanNeelam Varma Original Article 24 November 2018 Pages: 341 - 348
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities Jennifer H. FosterPatrick A. ThompsonEric S. Schafer Original Article 28 November 2018 Pages: 349 - 360
Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea? Huangliang ZhengJiaqi LiYihui Deng Original Article 30 November 2018 Pages: 361 - 374
Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study Marianne PavelFrançoise Borson-ChazotDiego Ferone Original Article 08 December 2018 Pages: 375 - 385
Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion Abeer F. AlharbiRobert A. KratzkeMark N. Kirstein Short Communication 12 December 2018 Pages: 387 - 391
